Parkwalk is the UK’s most active investor in university spinouts, backing transformative technologies developed by the country’s leading universities and research organisations. Parkwalk focuses on investing in companies addressing real-world challenges with IP-protected innovations across a broad range of sectors, including life sciences, artificial intelligence, quantum computing, advanced materials, genomics, cleantech, future mobility, medtech and big data.
As the leading growth EIS fund manager, with £400 million in assets under management, Parkwalk has invested in over 200 companies through its Parkwalk Opportunities and Knowledge Intensive EIS Funds, as well as through enterprise and innovation funds managed for the Universities of Cambridge, Oxford, Bristol and Imperial College. In 2025, Parkwalk introduced the Northern Universities Venture Fund, targeting opportunities emerging from the Universities of Leeds, Liverpool, Manchester and Sheffield.
If you'd like to be introduced to the team at Parkwalk, get in touch.
Request a meeting
